TAMBASCO, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 2.282
EU - Europa 2.051
AS - Asia 1.605
SA - Sud America 306
AF - Africa 53
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.305
Nazione #
US - Stati Uniti d'America 2.226
IT - Italia 743
SG - Singapore 728
IE - Irlanda 282
CN - Cina 259
BR - Brasile 233
HK - Hong Kong 205
RU - Federazione Russa 199
UA - Ucraina 198
VN - Vietnam 164
DE - Germania 130
FR - Francia 126
FI - Finlandia 92
NL - Olanda 62
SE - Svezia 62
GB - Regno Unito 60
KR - Corea 55
IN - India 45
CA - Canada 34
AR - Argentina 31
IQ - Iraq 25
BD - Bangladesh 20
CH - Svizzera 17
TR - Turchia 17
PL - Polonia 15
ZA - Sudafrica 15
JP - Giappone 14
AT - Austria 13
MX - Messico 12
SA - Arabia Saudita 12
UZ - Uzbekistan 11
CO - Colombia 10
BE - Belgio 9
EC - Ecuador 9
ES - Italia 9
VE - Venezuela 9
LT - Lituania 8
TN - Tunisia 8
ID - Indonesia 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
MY - Malesia 6
AU - Australia 5
JO - Giordania 4
KE - Kenya 4
PK - Pakistan 4
UY - Uruguay 4
CL - Cile 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
PY - Paraguay 3
SI - Slovenia 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 6.305
Città #
Singapore 509
Chandler 314
Dublin 282
Hong Kong 204
San Jose 184
Ashburn 157
San Mateo 146
Jacksonville 109
Boardman 106
Perugia 91
Santa Clara 75
Beijing 72
Altamura 71
Moscow 71
Medford 61
Princeton 61
Milan 60
Lauterbourg 57
Lawrence 57
Munich 55
Seoul 53
The Dalles 50
Wilmington 48
Los Angeles 44
Rome 41
Ho Chi Minh City 38
Ann Arbor 36
Dong Ket 29
New York 27
São Paulo 26
Helsinki 25
Andover 24
Hanoi 24
Turku 23
Orem 19
Des Moines 18
Piscataway 18
Bologna 17
Saint Petersburg 17
San Paolo di Civitate 16
Genoa 15
Montreal 15
Frankfurt am Main 14
Tokyo 14
Brooklyn 13
Houston 13
London 12
Modena 12
Baghdad 11
Denver 11
Warsaw 11
Chennai 10
Verona 10
Brussels 9
Falls Church 9
Izmir 9
Johannesburg 9
Manchester 9
Padova 9
Redmond 9
Tashkent 9
Atlanta 8
Columbus 8
Dallas 8
Mexico City 8
Rio de Janeiro 8
Laion 7
Nuremberg 7
Parma 7
Stockholm 7
Woodbridge 7
Amsterdam 6
Can Tho 6
Chicago 6
Da Nang 6
Lucca 6
Norwalk 6
Poplar 6
Shanghai 6
Trento 6
Turin 6
West Jordan 6
Belo Horizonte 5
Boston 5
Charlotte 5
City of London 5
Erbil 5
Florence 5
Formosa 5
Hải Dương 5
Medellín 5
Mumbai 5
Phoenix 5
Redwood City 5
San Francisco 5
Toronto 5
Villongo 5
Amman 4
Buenos Aires 4
Carlentini 4
Totale 3.796
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 756
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 133
Hippocampal epileptogenesis in autoimmune encephalitis 131
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 127
A magnetization transfer study of mild and advanced Parkinson's disease. 124
Cerebrospinal fluid biomarkers in Parkinson disease. 121
Acute dystonia induced by the combination of midodrine and perphenazine. 120
Clinical aspects and management of levodopa-induced dyskinesia. 120
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 120
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 113
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 109
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 108
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 107
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 106
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 104
Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using 123I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT) 103
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 101
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 101
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 101
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes 100
Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism 99
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 99
Brain CT scan in acute ischemic stroke: early signs and functional outcome. 97
A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline 97
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 97
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 96
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 96
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study 95
Multimodal use of computed tomography in early acute stroke, part 2. 94
CSF Biomarkers in Parkinson's disease 93
Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. 91
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease 90
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 90
Young Neurologists and Trainees Stroke Subspecialty Working Group. Educational approach on stroke training in Europe. 89
Levodopa in parkinson’s disease: Current status and future developments 87
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson's Disease Patients. 82
The Brain Dopaminergic System and Hyperthermia: The Neuroleptic Malignant Syndrome and The Parkinsonism-hyperpyrexia Syndrome 80
Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome. 80
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 79
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. 79
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. 79
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 79
Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system. 79
Magnetization transfer changes of grey and white matter in Parkinson’s disease 78
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 78
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 78
Multimodal use of computed tomography in early acute stroke, part 1. 77
Levodopa treatment in Parkinson's disease: earlier or later? 77
Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease. 76
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 75
Hot water epilepsy and Mccune-Albright syndrome: a case report. 74
Multimodal use of computed tomography in early acute stroke 73
Long-term follow-up in pediatric patients with paroxysmal hypothermia (Shapiro's syndrome) 72
Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings. 71
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease. 71
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 68
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 67
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 66
Prognostic factors in children with PRES and hematologic diseases 64
Movement disorders in 2016: from genes to phenotypes 54
Secondary prevention of cardioembolic stroke: oldest and newest promises. 53
Age-Related Decline in Disengaging Spatial Attention in Physiological Aging 52
Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences 44
Totale 6.439
Categoria #
all - tutte 26.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 0 0 0 14 33 33
2021/2022497 7 104 7 7 17 9 10 144 29 23 70 70
2022/20231.004 66 225 15 74 68 101 4 36 374 5 25 11
2023/2024494 29 43 29 9 9 3 94 11 59 21 94 93
2024/20251.153 27 78 39 78 126 78 63 61 209 83 210 101
2025/20262.299 161 179 147 366 331 202 371 131 233 178 0 0
Totale 6.439